Screener
Chemours CC Equity Method Income
Equity Method Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Chemours in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.
The source filing: Chemours’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 11:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001627223-26-000024
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Research and development expense | 27 | 28 | 53 | 55 |
| Restructuring, asset-related, and other charges | 3 | 18 | 16 | 51 |
| Total other operating expenses | 499 | 470 | 685 | 653 |
| Equity in earnings of affiliates | 9 | 9 | 17 | 17 |
| Interest expense, net | (68) | (67) | (137) | (133) |
| Loss on extinguishment of debt | (2) | — | (11) | — |
| Other income, net | 273 | 2 | 296 | 6 |
| Loss before income taxes | (1) | (248) | (22) | (249) |
Item 1. INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Chemours's equity method income?
- Chemours (CC) reported equity method income of $9M in Q2 2026.
- How has Chemours's equity method income changed year-over-year?
- Chemours's equity method income decreased by 0.0% year-over-year, from $9M to $9M.
- What is the long-term trend for Chemours's equity method income?
- Over 4 years (2021 to 2025), Chemours's equity method income has grown at a -5.7% compound annual growth rate (CAGR), from $43M to $34M.
- What does equity method income mean?
- The company's proportional share of net income or loss from unconsolidated affiliates and joint ventures accounted for under the equity method.
Ask your AI about Chemours's equity method income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude